Allergy


Ectoin® Allergy Nasal Spray 2%

The innovation for treatment and prevention of allergic rhinitis symptoms

Claims

Nasal Spray for treatment and prevention of allergic rhinitis symptoms.

  • Reduces allergen induced inflammation of the nasal mucosa.
  • Alleviates allergic symptoms (itchy and runny nose, sneezing, nasal congestion).
  • Supports the regeneration process of irritated nasal mucosa caused by allergens.
  • Reduces harmful influences of allergens and airborne particles.

Ingredients

Ectoin®, Sea Salt, Water.

Suitable for

Infants, children, adolescents and adults.

Dosage Forms

20 ml solution in bottle with dosage pump

 Study Overview

Werkhäuser et. al., 2014; Sonnemann et. al., 2014; Eichel et. al., 2014; Abdulkerimov et. al., 2016; Minaeva et. al., 2015

  • Tested against standard OTC drugs and placebo: As effective as cromoglicic acid, beclomethasone or azelastine-containing nasal sprays.
  • Seven studies including nearly 400 patients prove: significant improvement of local symptoms and excellent safety profile.

Status (EU): Medical Device Class Is (under approval)


Ectoin® Allergy Eye Drops 2%

The innovation for treatment and prevention of allergic conjunctivitis symptoms

Claims

Eye drops for treatment and prevention of allergic conjunctivitis symptoms.

  • Reduces allergen induced inflammation of the conjunctiva.
  • Alleviates allergic symptoms (red, itchy and watery eyes).
  • Protects against the harmful influences of allergens.
  • Supports the regeneration process of irritated and sensitive conjunctiva.

Ingredients

Ectoin®, Sodium Chloride, Hydroxyethyl Cellulose, Citrate Buffer, Water.

Suitable for

Children, adolescents and adults.

Dosage Forms

0.5 ml solution in single-dose ampoules or 10 ml in a multidose dropper (OSD or 3K)

 Study Overview

Salapatek et. al., 2011; Werkhäuser et. al., 2014; Skrypnyk 2015; Allegri et. al., 2014; Drozhzhina and Troichenko, 2015

  • Tested against standard OTC drugs and placebo: as effective as azelastine and ketotifen-containing eye drops.
  • Excellent tolerability and safety proven in children and adults.

Status (EU): Medical Device Class IIa


Ectoin® Allergy Lozenges

Effective protection against allergic symptoms in mouth and throat

Claims

Lozenges for treatment and prevention of allergic symptoms in mouth and throat, caused by airborne allergens like pollen, house dust or animal hair.

  • Reduces typical allergic symptoms in mouth and throat like sore throat or itchy palate.
  • Forms a natural and moisturizing protective shield on irritated mucous membranes in mouth and throat.
  • Stabilizes the cell membranes of the mucosa in mouth and throat and prevents irritations.
  • Hydrates dry epithelia and supports their regeneration.
  • Suitable for vegetarians.

Ingredients

Ectoin®, Isomalt, Sucralose, [Menthol, Citric Acid, Lemon Mint Flavour (containing tocopherol), Honey Flavour (containing polyethylene glycol)], Safflor Concentrate, Glucose Syrup, Water.

Suitable for

Children older than 6 years, adolescents and adults.

Dosage Forms

Blister strips containing 8 lozenges à 2.3 g

 Study Overview

Coming soon: Multicentre, prospective, randomized clinical trial: Use of Ectoin® Lozenges for the treatment of oropharyngeal allergic symptoms.
 

Status (EU): Medical Device Class IIa (under approval)